After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma After a faltering start, Japan’s biosimilars marketplace appears on the cusp of rapid growth. 01022024160133
Case Study Biotech and Pharmaceuticals Supporting an Emerging Biopharma To Build Out AI With Confidence October 22, 2024
Executive Insights Contract/Pharma Services Key Trends for CDMOs Partnering With Cell Therapy Developers July 11, 2024
Executive Insights Mental and Behavioral Health Psychedelics and Psychotherapy: A Treatment Paradigm for the Future? March 27, 2024
Published Articles Digital Embracing AI: A Guide for CEOs to Lead the Digital Charge January 31, 2024
Published Articles Biotech and Pharmaceuticals EU Pharmaceutical Legislation Revisions: What Are the Implications for Biopharma? December 20, 2023